NIH-funded research Fellowship grant

How sphingomyelin metabolism affects lung inflammation from silica exposure

Official title: Sphingomyelin Metabolism Impacts on Crystalline Silica-Induced Outcomes

Funded at University of Montana · NIH-10997169 · Data updated 2026-11-12

This study is looking at how tiny silica particles can cause long-lasting lung problems and inflammation, and it hopes to find new ways to help people with these issues by understanding how certain cells in the body react to the silica.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Montana
NIH-funded
Lab location1 site (Missoula, United States)
Project startAugust 12, 2024
Project endAugust 11, 2026
Funding year2024
Award (this year)$38,800
NIH project number1F31AI181539-01A1
Project IDNIH-10997169 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been exposed to crystalline silica and are experiencing chronic lung inflammation or related diseases.

Less likely to help

Patients who do not have a history of exposure to crystalline silica or similar environmental particles may not benefit from this research.

What this research studies

This research investigates how exposure to crystalline silica particles can lead to chronic inflammation and lung diseases. It focuses on the role of sphingomyelin metabolism in the process of lysosome membrane permeabilization, which can trigger cell death and inflammation in macrophages. By understanding these mechanisms, the research aims to identify potential new therapies to treat chronic inflammation caused by silica exposure. Patients may benefit from insights that could lead to improved treatment options for lung conditions related to silica and other harmful particles.

Why it matters

Potential benefit: If successful, this research could lead to novel therapies that effectively reduce chronic inflammation and improve lung health for affected patients.

How similar studies have gone: Previous research has shown promising results in understanding inflammation mechanisms related to particle exposure, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Montana
    Missoula, United States
    Active

Researchers

  • Principal investigator: Albright, Jacob — University of Montana
  • Study coordinator: Albright, Jacob

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.